Log in to save to my catalogue

The Anti-HIV Pentameric Pseudopeptide HB-19 is Preferentially Taken up in vivo by Lymphoid Organs Wh...

The Anti-HIV Pentameric Pseudopeptide HB-19 is Preferentially Taken up in vivo by Lymphoid Organs Wh...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18130874

The Anti-HIV Pentameric Pseudopeptide HB-19 is Preferentially Taken up in vivo by Lymphoid Organs Where It Forms a Complex with Nucleolin

About this item

Full title

The Anti-HIV Pentameric Pseudopeptide HB-19 is Preferentially Taken up in vivo by Lymphoid Organs Where It Forms a Complex with Nucleolin

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2001-11, Vol.98 (24), p.14090-14095

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

The HB-19 pseudopeptide 5[Kψ(CH2N)PR]-TASP, ψ(CH2N) for reduced peptide bond, is a specific inhibitor of HIV infection in different CD4+cell lines and in primary T-lymphocytes and macrophages. It blocks virus-particle attachment to permissive cells by binding and forming a stable complex with nucleolin expressed on the cell surface. Here, we have i...

Alternative Titles

Full title

The Anti-HIV Pentameric Pseudopeptide HB-19 is Preferentially Taken up in vivo by Lymphoid Organs Where It Forms a Complex with Nucleolin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_18130874

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_18130874

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.221467298

How to access this item